Navigation Links
Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
Date:12/9/2008

delivered by CPX-351 to human leukemia xenografts is associated with liposome-mediated bone marrow drug accumulation, intracellular delivery of encapsulated agents to leukemia cells, and increase efficacy.

Poster presented Saturday, December 6, 2008.

ASH Abstract # 2984

Feldman EJ, Lancet J, Kolitz EJ, et al. Phase 1 study of a liposomal carrier (CPX-351) containing a synergistic, fixed molar ratio of cytarabine (Ara-C) and daunorubicin (DNR) in advanced leukemias.

Poster presented Monday, December 8, 2008.


'/>"/>
SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Frederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator(R) Pharmaceuticals
2. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
3. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
4. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
5. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference
6. Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
7. Memory Pharmaceuticals Receives NASDAQ Decisions
8. MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference
9. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
10. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
11. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...
(Date:12/6/2009)... Belluck & Fox, LLP says dangerous substances such as asbestos have ... ... New York, NY (PRWEB) December 6, 2009 -- As parents ... alert to reports of recalls due to lead paint or asbestos ... 230,000 children visit hospital emergency rooms each year due to toy-related ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
(Date:12/4/2009)... KPMG LLP employees came together in more than 90 offices ... combines the audit, tax and advisory firm,s support for literacy ... our firm,s long history of volunteerism. Instead of holiday parties, ... the holidays for some children," said Tim Flynn, Chairman of ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
... N.C., April 21 Sicel ... company, today announced that it has entered into ... the world,s first passive (no battery), disposable, wireless ... threats in shipping containers using modified cell phone ...
... Inc. (Nasdaq: STXS ) announced today that it will ... 2009, on Thursday, May 7, 2009 before ... webcast on Thursday, May 7, 2009 at 8:30 a.m. ... and current corporate developments. The dial-in number for the conference call ...
... that reveals importance of Onboarding to improve HR processes; Intelius webinar ... ... April 21, 2009 -- Intelius Screening Solutions LLC, a leading, on-demand ... provider, has announced an agreement with onboarding pioneer KMS Software Company. ...
... NY, announces a newly updated, user-friendly, and informative website. The ... individuals and groups. , ... (PRWEB) ... Invacare walkers, Zipr Electric Scooters, Drive Medical aluminum rollators, and ...
... the DizzyFIX, is now available worldwide for self-directed home treatment of ... Paroxysmal Positional Vertigo). , ... Edmonton, Canada (PRWEB) April ... worldwide for self-directed home treatment of BPPV (Benign Paroxysmal ...
... Russell N. Olmsted, MPH, CIC, of Ann Arbor, Michigan ... Carole DeMille Achievement Award by the Association for Professionals ... annual award to an infection preventionist who best exemplifies ... control. The award will be presented at the APIC ...
Other Medicine News:Health News:World's First Disposable Wireless RFID Sensor Detects Radiation Threats in Shipping Containers Using Modified Cell Phone Technology 2Health News:World's First Disposable Wireless RFID Sensor Detects Radiation Threats in Shipping Containers Using Modified Cell Phone Technology 3Health News:Stereotaxis Announces First Quarter 2009 Earnings Release Date and Conference Call 2Health News:Intelius Screening Solutions Announces Agreement with KMS Software Company to Provide Pre-Integrated Employment Background Screening and Onboarding Solution 2Health News:Intelius Screening Solutions Announces Agreement with KMS Software Company to Provide Pre-Integrated Employment Background Screening and Onboarding Solution 3Health News:Intelius Screening Solutions Announces Agreement with KMS Software Company to Provide Pre-Integrated Employment Background Screening and Onboarding Solution 4Health News:Discount Medical Supplies Superstore Announces Newly Updated Website: Easy Shopping, Hundreds of Top Brands 2Health News:Discount Medical Supplies Superstore Announces Newly Updated Website: Easy Shopping, Hundreds of Top Brands 3Health News:Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo 2Health News:Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo 3Health News:Michigan Infection Preventionist Receives Carole Demille Award for Outstanding Service, Contribution to Profession 2Health News:Michigan Infection Preventionist Receives Carole Demille Award for Outstanding Service, Contribution to Profession 3
(Date:12/4/2009)... 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ... that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market its 8mg ramelteon ... by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...
(Date:12/4/2009)... Depression, anxiety disorder, bipolar disorder, Attention Deficit ... are among the comorbidities reported to occur more ... diagnosed with epilepsy versus those without an epilepsy ... households across the U.S. ,, Findings from " ...
(Date:12/3/2009)... (Nasdaq: PCYC ), a biopharmaceutical company focused on ... treatment of immune mediated diseases and cancer, today announced ... on, Tuesday, December 8, 2009 at 11:00am Eastern Time ... clinical data regarding its HDAC Program (PCI-24781) and its ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Unified360 Makes Positive Impact to Baylor Surgical Center Operations 53115 1Unified360 Makes Positive Impact to Baylor Surgical Center Operations 53115 2ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2009 Financial Results 53111 1Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL OSCO 28R 29 53106 1Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL OSCO 28R 29 53106 2Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL OSCO 28R 29 53106 3
... INNOVIVE Pharmaceuticals,Inc. (OTCBB: IVPH) today announced that ... INNO-406, an orally bioavailable dual Bcr-Abl and,Lyn-kinase ... will be,presented at the 43rd American Society ... place June 1- 5, 2007 at McCormick ...
... ROCKVILLE, Md.--(BUSINESS WIRE)--May 30, 2007 - Rexahn,Pharmaceuticals, ... the discovery, development, and commercialization of,innovative treatments ... and other unmet medical needs, today announced,that ... I clinical,trial of the Company's lead cancer ...
Other Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
... design allows the clinician to decide ... or when to take advantage of ... method to deliver compression to leg ... Garment Detection: Automatically detects type of ...
The choice for inclement weather. This boot provides both closed toe and heel with a moisture resistant vinyl upper....
... assay for the qualitative and ... to Gliadin in human serum. ... to be used as an ... gastrointestinal disorders, manily Coelic Disease. ...
... a given with our High Beam TriLens fiber ... remarkably brilliant 11.5 cm spot at a 40 ... class. , ,To achieve this unequaled performance in ... three of the finest Mag-Fluoride coated lenses and ...
Medicine Products: